Freenome, Inc. (FRNM) vs Atrium Therapeutics, Inc. (RNA)
A side-by-side comparison of Freenome, Inc. and Atrium Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FRNM
Freenome, Inc.
$16.59HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
RNA
Atrium Therapeutics, Inc.
$7.99HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — FRNM vs RNA
growth of $100 · dividends reinvested · last 1yFRNM +52.9% (+52.9%/yr)RNA -38.4% (-38.4%/yr)FRNM compounded faster over this window
FRNM RNA
Metrics side by side
FRNM is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.